(NP (NP (DT A) (JJ critical) (NN role)) (PP (IN of) (NP (ADJP-COOD (ADJP (NP (NN Sp1-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ Ets-related))) (NN transcription) (NNS factors))) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG maintaining) (NP (NP (JJ CTL-specific) (NN expression)) (PP (IN of) (NP (DT the) (NN mouse) (NN perforin) (NN gene))))))) (. .))
(S (NP-SBJ-1 (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (NP-2 (-NONE- *-1)) (S (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ potential) (NNS cis-elements)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (DT the) (NN mouse) (NN perforin) (NN gene)))))))))))) (. .))
(S (NP-SBJ (NP (NP (NN DNase) (CD I) (JJ hypersensitive) (NN site)) (PRN (-LRB- -LRB-) (NP (NN DHS)) (-RRB- -RRB-))) (NN mapping)) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (DT the) (NN perforin) (NN locus)) (VP-COOD (VP (VBD contained) (NP-100 (CD six) (NN DHS)) (PP-101 (IN within) (NP (NP (CD 7.0) (NN kb)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ 5') (JJ upstream)) (NN sequence)) (PRN (-LRB- -LRB-) (NP (CD -7.0) (NN kb)) (-RRB- -RRB-))))))) (CC and) (VP (NP=100 (CD two) (NN DHS)) (PP=101 (IN in) (NP (NN intron) (CD 2)))))))) (. .))
(S (NP-SBJ-3 (DT The) (NP-COOD (NP (CD six) (ADJP (JJ 5') (JJ upstream)) (NP (-NONE- *RNR*-102))) (CC and) (NP (CD one) (JJ intronic) (NP (-NONE- *RNR*-102)))) (NP-102 (NN DHS))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-3)) (PP (IN in) (NP (RB only) (JJ perforin-expressing) (NNS lymphocytes))))) (. .))
(S (NP-SBJ-4 (NP (NP (NP (NN Chloramphenicol) (NN acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NNS activities)) (VP (VBN directed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (ADJP (JJ 5') (JJ upstream)) (NN promoter))))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-4)) (ADVP (RB preferentially)) (PP (IN in) (NP (JJ perforin-expressing) (NN cell) (NNS lines))))) (. .))
(S-COOD (S (NP-SBJ (NP (DT A) (NN construct)) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN PFP5a)))) (VP (VBG containing) (NP (CD -795) (NN bp)))) (VP (VBD exhibited) (NP (DT the) (JJS highest) (NN CAT) (NN activity)))) (, ,) (CC and) (S (NP-SBJ (NP (NN PFP9a20)) (VP (VBG containing) (NP (RB only) (CD -73) (NN bp)))) (ADVP (RB also)) (VP (VBD produced) (NP (ADJP (RB significantly) (JJ high)) (NN CAT) (NN activity)) (PP (IN in) (NP (NN CTLL-R8) (NNS cells))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ proximal) (NN region)) (PP (IN in) (NP (NN PFP9a20)))) (VP (VBD contained) (NP-COOD (NP (NP (CD two) (JJ potential) (NN Sp1) (NN binding) (NNS sites)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN GC) (NN box)) (CC and) (NP (NN GT) (NN box))) (-RRB- -RRB-))) (CC and) (NP (NP (CD one) (NN Ets) (NN binding) (NN site)) (PRN (-LRB- -LRB-) (NP (NN EBS)) (-RRB- -RRB-))))) (. .))
(S (NP-SBJ (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT each)) (PP (IN of) (NP (DT the) (NNS cis-elements)))) (VP (VBD bound) (NP (JJ specific) (NN protein) (NNS factors)))))) (. .))
(S (SBAR-TMP (WHADVP-5 (WRB When)) (S (NP-SBJ-6 (JJ single-point) (NN mutation)) (VP (VBD was) (VP (VBN introduced) (NP (-NONE- *-6)) (PP (TO to) (NP (NP (DT each) (NP-COOD (NP (NN GC) (NN box)) (, ,) (NP (NN EBS)) (, ,) (CC and) (NP (NN GT) (NN box)))) (PP (IN in) (NP (NN PFP9a20))))) (ADVP (-NONE- *T*-5)))))) (, ,) (NP-SBJ-7 (ADJP (QP (IN at) (JJS least) (RB 3-fold)) (JJR less)) (NN CAT) (NN activity)) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-7)) (PP (IN in) (NP (NN CTLL-R8) (NNS cells))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (DT the) (CD three) (JJ cis-acting) (NNS elements))) (PP (IN in) (NP (DT the) (NN perforin) (NN gene) (NN expression))))))) (, ,) (NP-SBJ-8 (NN point) (NN mutation)) (VP (VBD was) (VP (VBN introduced) (NP (-NONE- *-8)) (ADVP-TMP (RB again)) (PP (TO to) (NP (NP (DT each) (JJ proximal) (NP-COOD (NP (NN GC) (NN box)) (, ,) (NP (NN EBS)) (, ,) (CC and) (NP (NN GT) (NN box)))) (PP (IN of) (NP (NN PFP5a))))))) (. .))
(S (NP-SBJ (DT The) (NN point) (NNS mutations)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (QP (CD 2.5-) (TO to) (JJ 3-fold)) (NN reduction)) (PP (IN of) (NP (NN CAT) (NN activity)))))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (NN combination)) (PP (IN of) (NP (DT the) (CD three) (JJ proximal) (JJ cis-acting) (NNS elements)))) (VP (MD may) (VP (VB constitute) (NP (NP (DT a) (JJ minimal) (NN region)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ CTL-specific) (NN expression)) (PP (IN of) (NP (NN perforin)))))))))))) (. .))
